PLSE
Price
$14.89
Change
+$0.18 (+1.22%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
989.6M
One day until earnings call
STXS
Price
$2.54
Change
+$0.04 (+1.60%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
225.63M
87 days until earnings call
Interact to see
Advertisement

PLSE vs STXS

Header iconPLSE vs STXS Comparison
Open Charts PLSE vs STXSBanner chart's image
Pulse Biosciences
Price$14.89
Change+$0.18 (+1.22%)
Volume$2.53K
Capitalization989.6M
Stereotaxis
Price$2.54
Change+$0.04 (+1.60%)
Volume$805
Capitalization225.63M
PLSE vs STXS Comparison Chart in %
Loading...
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLSE vs. STXS commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLSE is a Hold and STXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (PLSE: $14.71 vs. STXS: $2.50)
Brand notoriety: PLSE and STXS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PLSE: 62% vs. STXS: 234%
Market capitalization -- PLSE: $989.6M vs. STXS: $225.63M
PLSE [@Pharmaceuticals: Other] is valued at $989.6M. STXS’s [@Pharmaceuticals: Other] market capitalization is $225.63M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $168.51B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLSE’s FA Score shows that 0 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • PLSE’s FA Score: 0 green, 5 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, STXS is a better buy in the long-term than PLSE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLSE’s TA Score shows that 2 TA indicator(s) are bullish while STXS’s TA Score has 5 bullish TA indicator(s).

  • PLSE’s TA Score: 2 bullish, 6 bearish.
  • STXS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, STXS is a better buy in the short-term than PLSE.

Price Growth

PLSE (@Pharmaceuticals: Other) experienced а -0.27% price change this week, while STXS (@Pharmaceuticals: Other) price change was +12.61% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.27%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +3.27%.

Reported Earning Dates

PLSE is expected to report earnings on Aug 12, 2025.

STXS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.27% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLSE($990M) has a higher market cap than STXS($226M). STXS YTD gains are higher at: 9.649 vs. PLSE (-15.508). STXS has higher annual earnings (EBITDA): -24.72M vs. PLSE (-62.52M). PLSE has more cash in the bank: 119M vs. STXS (10.6M). STXS has less debt than PLSE: STXS (5.87M) vs PLSE (8.58M). STXS has higher revenues than PLSE: STXS (27.5M) vs PLSE (0).
PLSESTXSPLSE / STXS
Capitalization990M226M438%
EBITDA-62.52M-24.72M253%
Gain YTD-15.5089.649-161%
P/E RatioN/AN/A-
Revenue027.5M-
Total Cash119M10.6M1,123%
Total Debt8.58M5.87M146%
FUNDAMENTALS RATINGS
PLSE vs STXS: Fundamental Ratings
PLSE
STXS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
88100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
8243
P/E GROWTH RATING
1..100
10060
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PLSE's Valuation (64) in the Medical Specialties industry is somewhat better than the same rating for STXS (100). This means that PLSE’s stock grew somewhat faster than STXS’s over the last 12 months.

PLSE's Profit vs Risk Rating (88) in the Medical Specialties industry is in the same range as STXS (100). This means that PLSE’s stock grew similarly to STXS’s over the last 12 months.

PLSE's SMR Rating (98) in the Medical Specialties industry is in the same range as STXS (100). This means that PLSE’s stock grew similarly to STXS’s over the last 12 months.

STXS's Price Growth Rating (43) in the Medical Specialties industry is somewhat better than the same rating for PLSE (82). This means that STXS’s stock grew somewhat faster than PLSE’s over the last 12 months.

STXS's P/E Growth Rating (60) in the Medical Specialties industry is somewhat better than the same rating for PLSE (100). This means that STXS’s stock grew somewhat faster than PLSE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLSESTXS
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
75%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 15 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 11 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
78%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBSDX50.140.39
+0.78%
Franklin S&P 500 Index D
NIEAX18.790.08
+0.43%
BNY Mellon International Equity A
PSECX18.800.06
+0.32%
1789 Growth and Income C
JAGTX72.970.12
+0.16%
Janus Henderson Glb Tech and Innovt T
NOMIX20.89N/A
N/A
Northern Mid Cap Index

PLSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with CERS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
-0.07%
CERS - PLSE
37%
Loosely correlated
-2.42%
VAPO - PLSE
31%
Poorly correlated
N/A
STXS - PLSE
31%
Poorly correlated
+14.16%
CLPT - PLSE
31%
Poorly correlated
+0.28%
TMCI - PLSE
31%
Poorly correlated
+7.92%
More

STXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with SMTI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then SMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
+14.16%
SMTI - STXS
39%
Loosely correlated
+1.81%
TWST - STXS
37%
Loosely correlated
+2.56%
PSNL - STXS
33%
Loosely correlated
-0.77%
BLFS - STXS
33%
Poorly correlated
N/A
VCYT - STXS
33%
Poorly correlated
-1.12%
More